Browsing Tag
oncology immunotherapy
1 post
PDS Biotechnology Corporation strengthens PDS0101 intellectual property ahead of key regulatory milestones
PDS Biotechnology strengthens PDS0101 patent protection ahead of key Phase 3 and regulatory milestones. Find out what this means for investors.